The combined immunohistochemical expression of AMBRA1 and SQSTM1 identifies patients with poorly differentiated cutaneous squamous cell carcinoma at risk of metastasis: A proof of concept study
- Publication date
- 1 January 2024
- Publisher
- John Wiley and Sons Inc